Clinical Trials in Arizona

Showing 6281-6300 of 12,706 trials

Dose-Escalation Study of HTX-034 Following Bunionectomy

NCT04398329

This is a Phase 1b/2, randomized, blinded, active-controlled study. Phase 1b will evaluate escalating doses of HTX-034 compared with bupivacaine HCl. Phase 2 will be a dose-expansion phase to evaluate additional subjects treated with the HTX-034 dose selected based on Phase 1b compared with bupivacaine HCl.

Bunions

Heron Therapeutics73 participantsStarted May 2020

Phoenix, Arizona, United States • Bellaire, Texas, United States • San Antonio, Texas, United States +1 more locations

WITHDRAWNPhase 242 miles

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

NCT04982289

This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics (PD), immunogenicity, and efficacy of subcutaneous (SC) ALXN1830 in adults with generalized myasthenia gravis (gMG).

Generalized Myasthenia Gravis

Alexion Pharmaceuticals, Inc.Started Jan 2022

Phoenix, Arizona, United States

COMPLETEDPhase 242 miles

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

NCT03764072

This study will evaluate the dose-response relationship and safety of VX-150 in treating acute pain following bunionectomy.

Acute Pain

Vertex Pharmaceuticals Incorporated250 participantsStarted Dec 2018

Phoenix, Arizona, United States • Anaheim, California, United States • Pasadena, California, United States +3 more locations

Dose-Escalation Study of HTX-034 Following Bunionectomy

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

Find Trials by Condition in Arizona

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

X-82 to Treat Age-related Macular Degeneration

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients

PEN-866 in Patients With Advanced Solid Malignancies

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Expanded Access Remdesivir (RDV; GS-5734™)

Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease